Modeling Tumor Immunology and Immunotherapy in Mice

Trends in Cancer
Aitziber Buqué, Lorenzo Galluzzi

Abstract

Figure 1. Main Applications of Mouse Models for Tumor Immunology and Immunotherapy. Immunodeficient mice xenografted with human cancer cell lines have been at the foundation of in vivo cancer research for several decades, providing ground for the regulatory approval of multiple chemotherapeutics and targeted anticancer agents, but are intrinsically unsuitable for studying tumor immunology and immunotherapy. Similarly, patient-derived xenografts (PDXs) established in immunodeficient mice are not subjected to immunosurveillance by the host, although (depending on the protocol employed for PDX generation) some components of the patient's immune system may also be transferred to the mouse and be active, at least for some time. Considerable efforts are being devoted to the generation of humanized mice to circumvent these limitations. The establishment of PDXs in immunodeficient mice that are also engrafted with matched patient-derived peripheral blood mononuclear cells (PBMCs) is also being investigated as a means to screen for the efficacy of (immuno)therapeutic agents in support of clinical decision making. Mouse cancer cell lines grafted subcutaneously or orthotopically in immunocompetent syngeneic hosts have been instrumental fo...Continue Reading

Citations

Sep 4, 2019·International Journal of Cancer. Journal International Du Cancer·Jiahao ShiXianqun Fan
Mar 27, 2020·Journal for Immunotherapy of Cancer·Lorenzo GalluzziFrancesco M Marincola
Apr 3, 2020·Journal for Immunotherapy of Cancer·Luca MazzarellaGiuseppe Curigliano
May 18, 2020·International Journal of Cancer. Journal International Du Cancer·Mai F Tolba
Feb 6, 2020·Frontiers in Immunology·Steven Dow
Apr 30, 2020·Nature Reviews. Immunology·Giulia PetroniLorenzo Galluzzi
Aug 1, 2020·Nature Communications·Aitziber BuquéLorenzo Galluzzi
Oct 3, 2019·Cells·Cintia Carla da HoraBakhos A Tannous
May 23, 2019·Journal for Immunotherapy of Cancer·Davide BedognettiUNKNOWN Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Mar 23, 2020·Cancer Immunology, Immunotherapy : CII·Marina NatoliYumeng Mao
Sep 15, 2020·Oncoimmunology·Aitziber BuqueLorenzo Galluzzi
Oct 29, 2020·Cancer Metastasis Reviews·Rebecca M HarmanGerlinde R Van de Walle
Nov 27, 2020·Journal for Immunotherapy of Cancer·Nahee ParkYong Wha Moon
Nov 6, 2020·The Journal of Clinical Investigation·Kartik SehgalDavid A Barbie
Dec 19, 2020·Cancer Cell·Giulia PetroniLorenzo Galluzzi
Dec 11, 2020·Advanced Drug Delivery Reviews·Takahiro YamazakiFederico Pietrocola
Feb 13, 2020·Cancer Cell·Samirkumar B AminRoel G W Verhaak
Dec 30, 2020·Cancer Reports·Jan RemsikAdrienne Boire
Mar 7, 2021·Cancers·Ángela BellaFernando Aranda
Mar 10, 2021·Nature Reviews. Drug Discovery·Shawn P KubliTak W Mak
Apr 8, 2021·British Journal of Cancer·Maximilian BoeschMartin H Brutsche
Apr 21, 2021·ASN Neuro·Susann HetzeLennart Barthel
Aug 1, 2019·The Lancet Oncology·Eric DeutschGuido Kroemer
May 26, 2021·Seminars in Cancer Biology·Hong-My NguyenDipongkor Saha
Aug 20, 2021·Frontiers in Cell and Developmental Biology·Jiani YangYu Wang
Sep 2, 2021·Neuro-oncology Advances·Alexander F HaddadNicholas A Butowski
Feb 2, 2021·Neurosurgical Focus·Alexander F HaddadManish K Aghi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.